Austrália - inglês - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - citalopram hydrobromide, quantity: 12.49 mg (equivalent: citalopram, qty 10 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; lactose monohydrate; maize starch; copovidone; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - treatment of major depression

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - citalopram hydrobromide, quantity: 12.49 mg (equivalent: citalopram, qty 10 mg) - tablet, film coated - excipient ingredients: copovidone; microcrystalline cellulose; lactose monohydrate; magnesium stearate; croscarmellose sodium; maize starch; titanium dioxide; hypromellose; macrogol 400 - treatment of major depression

Arábia Saudita - inglês - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

gulf pharmaceutical industries (julphar) - ticlopidine hydrochloride - film-coated tablet - 250 mg

Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

impexeco - ticlopidine hydrochloride - film-coated tablet - 250 mg - ticlopidine hydrochloride 250 mg - ticlopidine

Armênia - inglês - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - tablets film-coated - 75mg+ 100mg

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - brexpiprazole, quantity: 0.25 mg - tablet, film coated - excipient ingredients: magnesium stearate; hyprolose; lactose monohydrate; microcrystalline cellulose; maize starch; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red; iron oxide black - rexulti is indicated in adult patients for the treatment of schizophrenia.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - brexpiprazole, quantity: 0.5 mg - tablet, film coated - excipient ingredients: hyprolose; lactose monohydrate; microcrystalline cellulose; magnesium stearate; maize starch; titanium dioxide; hypromellose; purified talc; iron oxide yellow; iron oxide red - rexulti is indicated in adult patients for the treatment of schizophrenia.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - clopidogrel besilate, quantity: 111.86 mg (equivalent: clopidogrel, qty 75 mg) - tablet, film coated - excipient ingredients: lactose; glyceryl behenate; crospovidone; purified talc; microcrystalline cellulose; titanium dioxide; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease. acute coronary syndrome: clopidogrel is indicated in combination with aspirin for patients with: unstable angina or non-st-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). clopidogrel is indicated for treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or pci, with or without stent). st-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. in this population, clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - clopidogrel besilate, quantity: 111.86 mg (equivalent: clopidogrel, qty 75 mg) - tablet, film coated - excipient ingredients: crospovidone; lactose; purified talc; glyceryl behenate; microcrystalline cellulose; titanium dioxide; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - clopidogrel besilate, quantity: 111.86 mg (equivalent: clopidogrel, qty 75 mg) - tablet, film coated - excipient ingredients: lactose; crospovidone; microcrystalline cellulose; glyceryl behenate; purified talc; titanium dioxide; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.